Title : Cabozantinib in Thyroid Cancer.

Pub. Date : 2015

PMID : 26152149






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cabozantinib is an oral once-daily multitarget tyrosine kinase inhibitor of MET, VEGFR2, RET, acting against KIT, AXL, FLT3 and Tie-2. cabozantinib fms related receptor tyrosine kinase 3 Homo sapiens